Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Investigations on nanoconfinement of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug targeting.

Tomoiaga AM, Cioroiu BI, Nica V, Vasile A.

Colloids Surf B Biointerfaces. 2013 Nov 1;111:52-9. doi: 10.1016/j.colsurfb.2013.05.019. Epub 2013 May 20.

PMID:
23777792
2.

Magnetic Core-Shell Silica Nanoparticles with Large Radial Mesopores for siRNA Delivery.

Xiong L, Bi J, Tang Y, Qiao SZ.

Small. 2016 Sep;12(34):4735-42. doi: 10.1002/smll.201600531. Epub 2016 May 19.

PMID:
27199216
3.

Optimization of synthesis parameters for mesoporous shell formation on magnetic nanocores and their application as nanocarriers for docetaxel cancer drug.

El-Toni AM, Ibrahim MA, Labis JP, Khan A, Alhoshan M.

Int J Mol Sci. 2013 May 30;14(6):11496-509. doi: 10.3390/ijms140611496.

4.

Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.

Park SB, Joo YH, Kim H, Ryu W, Park YI.

Mater Sci Eng C Mater Biol Appl. 2015 May;50:64-73. doi: 10.1016/j.msec.2015.01.073. Epub 2015 Jan 24.

PMID:
25746247
5.

Phase behavior of poly(sulfobetaine methacrylate)-grafted silica nanoparticles and their stability in protein solutions.

Dong Z, Mao J, Yang M, Wang D, Bo S, Ji X.

Langmuir. 2011 Dec 20;27(24):15282-91. doi: 10.1021/la2038558. Epub 2011 Nov 29.

PMID:
22124164
6.

Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.

Kwon S, Singh RK, Kim TH, Patel KD, Kim JJ, Chrzanowski W, Kim HW.

Acta Biomater. 2014 Mar;10(3):1431-42. doi: 10.1016/j.actbio.2013.10.028. Epub 2013 Nov 15.

PMID:
24239681
7.

Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications.

Rosenholm JM, Lindén M.

J Control Release. 2008 Jun 4;128(2):157-64. doi: 10.1016/j.jconrel.2008.02.013. Epub 2008 Mar 6.

PMID:
18439699
8.

Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.

Ma X, Zhao Y, Ng KW, Zhao Y.

Chemistry. 2013 Nov 11;19(46):15593-603. doi: 10.1002/chem.201302736. Epub 2013 Oct 2.

PMID:
24123533
9.

Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.

Hartono SB, Gu W, Kleitz F, Liu J, He L, Middelberg AP, Yu C, Lu GQ, Qiao SZ.

ACS Nano. 2012 Mar 27;6(3):2104-17. doi: 10.1021/nn2039643. Epub 2012 Mar 12.

PMID:
22385282
10.

Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.

Sapino S, Ugazio E, Gastaldi L, Miletto I, Berlier G, Zonari D, Oliaro-Bosso S.

Eur J Pharm Biopharm. 2015 Jan;89:116-25. doi: 10.1016/j.ejpb.2014.11.022. Epub 2014 Dec 3.

11.

Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.

Li C, Yang D, Ma P, Chen Y, Wu Y, Hou Z, Dai Y, Zhao J, Sui C, Lin J.

Small. 2013 Dec 20;9(24):4150-9. doi: 10.1002/smll.201301093. Epub 2013 Jul 11.

PMID:
23843254
12.

Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.

He H, Xiao H, Kuang H, Xie Z, Chen X, Jing X, Huang Y.

Colloids Surf B Biointerfaces. 2014 May 1;117:75-81. doi: 10.1016/j.colsurfb.2014.02.014. Epub 2014 Feb 19.

PMID:
24632033
13.

Functionalized mesoporous silica particles for application in drug delivery system.

Pang J, Luan Y, Yang X, Jiang Y, Zhao L, Zong Y, Li Z.

Mini Rev Med Chem. 2012 Jul;12(8):775-88. Review.

PMID:
22512562
14.

Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.

Xuan S, Wang F, Lai JM, Sham KW, Wang YX, Lee SF, Yu JC, Cheng CH, Leung KC.

ACS Appl Mater Interfaces. 2011 Feb;3(2):237-44. doi: 10.1021/am1012358. Epub 2011 Jan 13.

PMID:
21229966
15.

Adsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticles.

Li X, Zhang J, Gu H.

Langmuir. 2011 May 17;27(10):6099-106. doi: 10.1021/la104653s. Epub 2011 Apr 13.

PMID:
21488610
16.

Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.

Tao C, Zhu Y.

Dalton Trans. 2014 Nov 7;43(41):15482-90. doi: 10.1039/c4dt01984a.

PMID:
25190592
17.

5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications.

Rejinold NS, Muthunarayanan M, Chennazhi KP, Nair SV, Jayakumar R.

Int J Biol Macromol. 2011 Jan 1;48(1):98-105. doi: 10.1016/j.ijbiomac.2010.10.003. Epub 2010 Oct 14.

PMID:
20951162
18.

Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging.

He Q, Ma M, Wei C, Shi J.

Biomaterials. 2012 Jun;33(17):4392-402. doi: 10.1016/j.biomaterials.2012.02.056. Epub 2012 Mar 16.

PMID:
22425026
19.

Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy.

Zhang Q, Neoh KG, Xu L, Lu S, Kang ET, Mahendran R, Chiong E.

Langmuir. 2014 Jun 3;30(21):6151-61. doi: 10.1021/la500746e. Epub 2014 May 21.

PMID:
24824061
20.

Embedding fluorescent mesoporous silica nanoparticles into biocompatible nanogels for tumor cell imaging and thermo/pH-sensitive in vitro drug release.

Gui R, Wang Y, Sun J.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:518-25. doi: 10.1016/j.colsurfb.2014.01.044. Epub 2014 Feb 6.

PMID:
24576821

Supplemental Content

Support Center